Patients waiting over two years for access to EU- approved medicines
Irish approvals process delays mean public patients forced to wait for new therapies already available to private patients
Oliver O'Connor
Warning for Ireland as EU falls behind on pharma R&D
Ireland has delivered on creating pharma clusters but needs to focus more on innovation and next generation medicines, says Ipha
Vaccine activists accuse Big Pharma of relying on public money
Waiving patent rights may have chilling effect on medicine development, industry warns
Covid-19: Vaccine industry and activists at odds over Trips waiver
Industry says waiver of IP rights not needed as vaccine supply far outweighs demand
Ireland slow to approve cancer medicines for patient use
Just half of 41 cancer drugs approved from 2017-2020 were available here at end of 2021
State slower to ‘adopt new drugs’ than most of western Europe
Medicines regularly not worth approving at asking price
Ireland an outlier without access to new cell and gene therapy, report says
Upfront costs high but treatments may cut long-term expense and boost patient results
Government and big pharma face clash on Covid-19 vaccine patent waiver
Two Ministers back US support for patent waiver opposed by pharmaceutical industry
Report highlights new medicines’ huge economic benefits to State
New medicines have cut number of years of life lost to heart disease by 34% since 2005
Pharma sector plays down prospect of Covid-19 vaccine production in the State
Major drug manufacturers already at full capacity producing other medications
State releases €30m to supply new medicines
Deal with pharma sector comes as talks on new drug pricing deal deferred until May
Three-quarters of people in Republic will take Covid vaccine, survey says
Study finds high proportion of people willing to get immunised against coronavirus
Restarting Ireland: When and how will we ‘get back to normal’?
Optimists say July. Others September. We will return – gradually – to a much changed world
Calls for new government to give faster access to life-saving drugs
Pharma group says eight cancer therapies awaiting HSE approval for over 900 days
Three in four Irish willing to test new treatments if ill
Almost half surveyed say cancer is the disease science has greatest potential to cure
Cancer drug trials hit by lack of funding , report warns
Government urged to improve focus on pharma research and access to medicines
Ireland compares poorly with Europe for access to medicines - report
Study examines access to 121 drugs approved since 2015 by EU regulator
Ten new medicines waited more than two years for HSE approval
Medicines generally blocked on basis of price as Ipha says delay ‘unacceptably long’
Shouting the loudest often proves the catalyst in a broken drug-approvals process
Spinraza is the latest in a series of controversial drugs that have put Ireland’s unique approval system in the spotlight
Drug companies angry at allegation of ‘predatory pricing’
Row between industry and body that advises the HSE over access to market for new medicines
Emergency medicines to be fast-tracked into State after Brexit
Revenue makes plans to avoid disruption to supplies after UK’s exit from the EU
Budget 2019: ‘It does nothing to address the crisis out there’
Housing, health, property and environmental groups react to the budget
Irish patients denied access to drugs made in Ireland
Pharma companies says drugs being exported to European markets but are not approved here
Big Pharma scathing on failure to endorse new cancer medicines
Cancer strategy targets ‘to be missed’ if new generation drugs not backed by Government
Pharma body calls for more State funding on medicines
Government to save €15m this year as prices fall across 750 drugs
Ireland urgently needs access to new drugs, says pharma body
Simon Harris signs agreement to make innovative medicines available to Irish patients
EU proposes waiver for manufacturers of generic drugs
Big pharma companies object to change that would allow generic manufacture of protected medicines for markets outside the bloc
Former government adviser joins pharma lobby group
Bernard Mallee appointed as IPHA’s director of communications and advocacy
Price pressure keeps nine new drugs from Irish patients
Cancer drugs feature in list of therapies waiting HSE approval on cost grounds
Nine new high-tech drugs to be made available to patients
Medicines for cancer, depression, heart disease to be used following HSE funding row
Crunch meeting fails to agree funding for new medicines
Drug companies told there is no budget and no plans for supplementary health budget
HSE runs out of money needed to provide new medicines to patients
Department says it is considering three medicines for approval
Cystic fibrosis drugs deal hailed as ‘massive victory’
Agreement testament to hard work of Cystic Fibrosis Ireland and patients, says Martin
Row over savings to State from ‘copycat’ drugs
Generics lobby says biosimilars are being blocked but pharma group disagrees
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices